Compass Therapeutics, Inc.
Compass Therapeutics, Inc. (CMPX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cmpx · stock forecast · 15 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 15 Wall Street analysts in the past 3 months
Buy
15 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$15.00
Consensus
$10.40
+415.1% upside
Low
$6.00
Median: $9 · Last Close: $2.02
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$10.40
415.1% upside
High Target
$15
643.0%
Low Target
$6
197.2%
Current Price
$2.02
as of today
Based on analyst price targets, the CMPX stock price prediction for the next 12 months ranges from $6 to $15. The consensus CMPX price forecast of $10.40 implies 415.1% upside from the current price of $2.02.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $2.04 | ↑ 0.90% |
1-day model range: $2.02–$2.05. Peak: $2.05 (+0.90%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CMPX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-28 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-04-28 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-04-27 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-04-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-24 | Guggenheim | Maintains | Buy→Buy |
| 2026-01-06 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-11-05 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-08-12 | Guggenheim | Maintains | Buy→Buy |
| 2025-08-12 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-05-09 | Guggenheim | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Compass Therapeutics, Inc. (CMPX) stock. Of the recent 51 rating actions, 2 were upgrades and 0 were downgrades. 15 analysts currently cover CMPX.
Analyst Recommendation Trends
CMPX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$-2M
↓ 101.9% YoY
Revenue Next Year
$26M
↓ 1179.1% YoY
EPS This Year
$-0.44
EPS Next Year
$-0.46
↑ 5.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast CMPX EPS of $-0.44 for the current fiscal year, based on estimates from 11 analysts. The CMPX revenue forecast is $-2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CMPX stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CMPX price target is $10.40 (+415.1% upside), with an analyst consensus of Buy.
The CMPX short-term stock prediction for tomorrow is $2.04 (+0.90%).
Compass Therapeutics, Inc. trades on NASDAQ under the ticker CMPX. The CMPX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
CMPX forecast · 8 questionsAccording to 15 Wall Street analysts, the average 12-month CMPX price target is $10.40, with a high forecast of $15.00 and a low of $6.00. The median price target is shown in the chart above when available. This implies +415.1% potential upside from the current price of $2.02.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.